Welcome to our dedicated page for Haleon plc American Depositary Shares (Each representing two Ordinary Shares) news (Ticker: HLN), a resource for investors and traders seeking the latest updates and insights on Haleon plc American Depositary Shares (Each representing two Ordinary Shares) stock.
Haleon plc (NYSE: HLN) is a global leader in consumer health, formed through the combination of consumer health divisions from GSK, Pfizer, and Novartis. Officially separated from GSK and listed on the stock market in July 2022, Haleon stands as one of the largest consumer health companies worldwide. The company generates 60% of its sales from globally recognized power brands such as Sensodyne, Advil, Centrum, and Poligrip, which are often market leaders in their categories. Additionally, Haleon boasts several strong local brands tailored to regional needs, including Emergen-C, Eno, Tums, and Caltrate. These brands effectively address various consumer health needs, from oral care and digestive health to pain relief and nutrition.
Haleon's commitment to consumer health is demonstrated through its significant investment in research and innovation. The company continually evolves its product portfolio, ensuring it meets the diverse health requirements of consumers globally. Recent achievements include the launch of the #ListenToPain initiative, which aims to improve pain management by enhancing communication between health professionals and patients. This program highlights Haleon's dedication to empathetic and individualized patient care.
Financially, Haleon maintains a robust position, backed by its extensive range of trusted products. The company has also engaged in strategic partnerships to further its mission of delivering better everyday health. Notably, Haleon's collaboration with the Economist Impact on the Health Inclusivity Index showcases its commitment to broadening healthcare accessibility and inclusivity worldwide.
Haleon's dynamic approach to consumer health is further evidenced by its proactive response to social issues. The company's latest study, the Haleon Pain Index, reveals societal attitudes towards pain post-pandemic and underscores the need for greater empathy and understanding in managing pain. This study aligns with global health directives from the World Health Organization and other leading health bodies, reinforcing Haleon's role as a thought leader in consumer health.
In addition to its core business operations, Haleon engages in innovative marketing strategies, as seen with the TUMS brand. The recent launch of the TUMS Bag in collaboration with designer Nik Bentel and the TUMS Prop Bites initiative with DraftKings highlight Haleon's creative approach to brand engagement and consumer interaction.
Haleon remains steadfast in its mission to enhance everyday health through trusted science, innovation, and deep human understanding. For more information, visit www.haleon.com.
Excedrin has launched the Head Care Club, a program designed to support everyday head health with routines from Emmy Award-winning choreographer Derek Hough. Research indicates that 70% of those experiencing migraines report a negative impact on their quality of life. The program promotes a holistic approach, encouraging proactive measures beyond just treating migraine attacks.
The new Head Care product line includes a daily dietary supplement and nutrient mixes aimed at improving head health. It emphasizes the need for mindfulness, nutrition, and movement to manage headaches and migraines effectively. Dr. Deena Kuruvilla, a neurologist, supports these methods, highlighting their potential benefits for overall brain health. Excedrin aims to enhance well-being via small lifestyle adjustments, reflecting its commitment to comprehensive headache management.
Haleon plc announced the redemption of its total outstanding $300 million Callable Floating Rate Senior Notes due 2024 by its subsidiary, GSK Consumer Healthcare Capital US LLC. The redemption is set for March 24, 2023, at a price equal to 100% of the principal amount plus any accrued interest. All noteholders will receive a notice of redemption from the trustee, Deutsche Bank Trust Company Americas, and the notes must be surrendered to collect the redemption price. This move underlines Haleon's financial strategy as it manages its debt obligations.
Haleon plc (LSE: HLN, NYSE: HLN) announced the expiration and final results of its exchange offers for seven series of unregistered notes issued by GSK Consumer Healthcare Capital. The offers, launched on September 29, 2022, expired on October 28, 2022. The Exchange Notes, which have been registered under the Securities Act, will replace the Original Notes. Settlement is expected on November 2, 2022. The primary aim was to provide holders of Original Notes with registered securities, eliminating prior transfer restrictions.
Haleon and Microsoft have partnered to enhance health product accessibility for individuals who are blind or have low vision. Launched on World Sight Day, the collaboration improves the Microsoft Seeing AI app, enabling detailed audio narrations for over 1,500 Haleon products across the U.S. and U.K. Users can scan barcodes to receive crucial information about product name, ingredients, and usage. This initiative aims to empower users in managing their health independently. Haleon also introduced its Health Inclusivity Index, aiming to enhance global health inclusivity.
Haleon plc (LSE: HLN, NYSE: HLN) announced the start of exchange offers for seven series of outstanding unregistered notes from GSK Consumer Healthcare Capital. The offers aim to exchange these unregistered notes for registered notes under the Securities Act, expected to be listed on the NYSE. The exchange period ends at 5:00 p.m. (Eastern time) on October 28, 2022, with settlement anticipated on November 2, 2022. A registration statement related to the exchange notes was filed with the SEC on the same date.
New results from the COSMOS-Mind study indicate that participants taking Centrum Silver exhibited significant improvements in cognitive function compared to those on placebo. This study, involving over 2,000 older adults, highlights the potential benefits of multivitamin supplementation in addressing cognitive decline, a major concern as aging populations grow. The findings suggest that Centrum Silver could enhance memory and executive function, stressing its importance for healthy aging. The detailed report is available in the Alzheimer & Dementia Journal.
Nicorette has launched SmokeLess Break Beats, a unique music therapy initiative aimed at supporting smokers in their cessation journey. Developed with Berklee Music and Health Institute, the program features eight original tracks designed to promote relaxation, focus, and confidence. Available for free on Spotify, these playlists serve as behavioral tools during typical smoke breaks. The initiative underscores the science behind music's ability to reduce cravings and enhance psychological well-being, increasing the effectiveness of Nicotine Replacement Therapy by up to 70%.
FAQ
What is the current stock price of Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN)?
What is the market cap of Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN)?
What is Haleon plc?
What are some of Haleon's major brands?
When did Haleon go public?
What is the #ListenToPain initiative?
What is the Haleon Pain Index (HPI)?
What recent marketing initiatives has Haleon launched?
How does Haleon contribute to health inclusivity?
What are Haleon's core business areas?
What is Haleon's approach to innovation?
Where can I find more information about Haleon?
